In part 1 of this 5-part series, panelists discuss early allergen introduction, oral immunotherapy, and Xolair for food allergy.
RX Review: Pediatric Allergy and Anaphylaxis Management in 2025
In part 2 of this 5-part series, panelists discuss confusion in food allergy diagnosis and the need for better medical education.
In part 3 of this 5-part series, panelists discuss the recent Neffy approval, oral immunotherapy, and Xolair’s role in allergy management.
In part 4 of this 5-part series, panelists discuss gaps in pediatric food allergy care, stressing better diagnosis, education, and management.
In the final part of this 5-part series, panelists discuss new allergy treatments such as Xolair, early immunotherapy, and their broader impact.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
ACIP votes to update hepatitis B vaccine recommendation for infants
2
New analysis highlights nirsevimab as most impactful RSV prevention strategy for infants
3
Repeal of nonmedical exemptions linked to rise in kindergarten vaccination rates
4
Christine Eng, MD, on addressing barriers to exome and genome sequencing in clinical practice
5
